As of 2026-04-13, the Fair Value of Graphite Bio Inc (LENZ) is -13.12 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.07 USD, the upside of Graphite Bio Inc is -244.69%.
With the market price of 9.07 USD and our fair value calculation, Graphite Bio Inc (LENZ) is not a good investment. Investing in LENZ stocks now will result in a potential loss of 244.69%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -70.76 | -101.05 | -124.65 | -49.77 | -82.13 | -85.67 |
| YoY growth | -3.50% | -42.81% | -23.36% | 60.07% | -65.02% | -14.92% |
| Market Cap (mil) | 283.80 |
| P/E | |
| Forward P/E |
| EPS | -2.62 |
| Avg earnings growth rate | -14.92% |
| TTM earnings | -82.13 |